Fund Holdings — Vestal Point Capital, LP

Total Portfolio Value:
$1.40B
Total Bought:
$535.98M
Total Sold:
$714.30M
Net Transaction:
-$178.31M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Arcellx Inc
COMMON STOCK
475,0002,387,720+1,912,720$36.43M$156.63M11.19%+$120.21M
Cytokinetics, Incorporated(CYTK)2,350,0002,590,531+240,531$110.54M$104.11M7.43%-$6.43M
Insmed Incorporated(INSM)900,0001,075,000+175,000$62.14M$82.01M5.86%+$19.88M
Nuvalent Inc600,0001,075,000+475,000$46.97M$76.24M5.44%+$29.27M
Vera Therapeutics, Inc.CL A(VERA)1,075,0002,500,000+1,425,000$45.46M$60.05M4.29%+$14.59M
KalVista Pharmaceuticals Inc4,770,0004,751,292-18,708$40.40M$54.83M3.92%+$14.43M
uniQure N.V.SHS(QURE)3,025,0004,792,572+1,767,572$53.42M$50.80M3.63%-$2.62M
Crinetics Pharmaceuticals Inc01,500,000+1,500,000$0$50.31M3.59%+$50.31M
Xenon Pharmaceuticals Inc.(XENE)810,0001,300,000+490,000$31.75M$43.62M3.11%+$11.86M
Scholar Rock Holding Corporation(SRRK)01,300,000+1,300,000$0$41.80M2.98%+$41.80M
Bicara Therapeutics Inc710,0002,768,975+2,058,975$12.37M$36.08M2.58%+$23.71M
Geron Corporation(GERN)11,000,00022,005,340+11,005,340$38.94M$34.99M2.50%-$3.95M
Amicus Therapeutics Inc
COM
3,350,0004,275,000+925,000$31.56M$34.88M2.49%+$3.33M
Immatics N.V.SHS(IMTX)6,275,0007,192,700+917,700$44.62M$32.44M2.32%-$12.18M
Structure Therapeutics IncADS1,725,0001,788,990+63,990$46.78M$30.97M2.21%-$15.81M
Dianthus Therapeutics, Inc.(DNTH)1,075,0001,700,069+625,069$23.43M$30.84M2.20%+$7.40M
Savara Inc.(SVRA)10,775,00011,000,000+225,000$33.08M$30.47M2.18%-$2.61M
Tyra Biosciences, Inc.(TYRA)990,0002,879,829+1,889,829$13.76M$26.78M1.91%+$13.02M
Danaher Corporation(DHR)0125,000+125,000$0$25.63M1.83%+$25.63M
UroGen Pharma Ltd.(URGN)1,630,0002,152,957+522,957$17.36M$23.81M1.70%+$6.45M
Ascendis Pharma A/SADR(ASND)520,000150,142-369,858$71.59M$23.40M1.67%-$48.19M
Astria Therapeutics Inc4,180,0004,180,0000$37.37M$22.32M1.59%-$15.05M
Day One Biopharmaceuticals Inc
COM
1,440,0002,598,127+1,158,127$18.24M$20.60M1.47%+$2.36M
Dyne Therapeutics, Inc.(DYN)01,800,000+1,800,000$0$18.83M1.34%+$18.83M
Ultragenyx Pharmaceutical Inc.(RARE)1,500,000500,000-1,000,000$63.10M$18.11M1.29%-$45.00M
Liquidia Corporation(LQDA)1,760,0001,227,403-532,597$20.70M$18.10M1.29%-$2.59M
Cogent Biosciences, Inc.(COGT)03,000,000+3,000,000$0$17.97M1.28%+$17.97M
Establishment Labs Holdings Inc.(ESTA)300,000433,193+133,193$13.82M$17.68M1.26%+$3.86M
Verona Pharma PLCADS495,000267,627-227,373$22.99M$16.99M1.21%-$6.00M
Perrigo Company plcSHS(PRGO)375,000587,649+212,649$9.64M$16.48M1.18%+$6.84M
GE HealthCare Technologies Inc.(GEHC)0204,130+204,130$0$16.48M1.18%+$16.48M
Nyxoah SASHS
SHS
2,924,2162,318,954-605,262$23.39M$16.19M1.16%-$7.21M
Globus Medical, Inc.CL A(GMED)325,000200,000-125,000$26.88M$14.64M1.05%-$12.24M
Nurix Therapeutics, Inc.(NRIX)485,0001,125,552+640,552$9.14M$13.37M0.95%+$4.23M
Sarepta Therapeutics, Inc.(SRPT)250,000200,000-50,000$30.40M$12.76M0.91%-$17.63M
Bruker Corporation(BRKR)0300,000+300,000$0$12.52M0.89%+$12.52M
Cidara Therapeutics Inc0504,542+504,542$0$10.87M0.78%+$10.87M
Black Diamond Therapeutics Inc5,600,0005,600,0000$11.98M$8.68M0.62%-$3.30M
MoonLake ImmunotherapeuticsCL A(MLTX)0200,000+200,000$0$7.81M0.56%+$7.81M
Solid Biosciences Inc2,850,0001,753,558-1,096,442$11.40M$6.49M0.46%-$4.91M
Immunovant, Inc.(IMVT)45,000350,000+305,000$1.11M$5.98M0.43%+$4.87M
Zymeworks Inc.(ZYME)185,000500,000+315,000$2.71M$5.96M0.43%+$3.25M
Applied Therapeutics Inc11,500,00011,500,0000$9.85M$5.62M0.40%-$4.22M
iTeos Therapeutics Inc900,000900,0000$6.91M$5.37M0.38%-$1.54M
Lakefront Biotherapeutics NVADR(LKFT)180,000200,000+20,000$4.95M$5.02M0.36%+$74.0K
Voyager Therapeutics, Inc.(VYGR)1,230,0001,249,418+19,418$6.97M$4.22M0.30%-$2.75M
Lexeo Therapeutics, Inc.(LXEO)1,200,0001,136,249-63,751$7.90M$3.94M0.28%-$3.95M
Kiniksa Pharmaceuticals International, plcCL A(KNSA)0169,864+169,864$0$3.77M0.27%+$3.77M
Celldex Therapeutics, Inc.(CLDX)305,000198,646-106,354$7.71M$3.61M0.26%-$4.10M
OnKure Therapeutics, Inc.CL A(OKUR)635,000635,0000$5.46M$2.73M0.19%-$2.73M
Ventyx Biosciences Inc2,000,0002,000,0000$4.38M$2.30M0.16%-$2.08M
Arcturus Therapeutics Holdings Inc.(ARCT)0211,790+211,790$0$2.24M0.16%+$2.24M
Passage Bio, Inc.(PASG)6,100,0006,100,0000$3.46M$2.15M0.15%-$1.31M
Fate Therapeutics, Inc.(FATE)2,465,0002,515,850+50,850$4.07M$1.99M0.14%-$2.08M
Alto Neuroscience, Inc.(ANRO)915,000915,0000$3.87M$1.98M0.14%-$1.89M
Sutro Biopharma, Inc.(STRO)2,570,0002,600,000+30,000$4.73M$1.69M0.12%-$3.04M
Engene Holdings Inc
COM
370,000370,0000$2.46M$1.66M0.12%-$802.9K
Alector Inc0504,540+504,540$0$620.6K0.04%+$620.6K
Atara Biotherapeutics Inc125,00094,085-30,915$1.66M$558.9K0.04%-$1.10M
Traws Pharma, Inc.(TRAW)75,000175,000+100,000$666.0K$402.5K0.03%-$263.5K
MacroGenics, Inc.(MGNX)280,000280,0000$910.0K$355.6K0.03%-$554.4K
Tenax Therapeutics, Inc.(TENX)55,18953,439-1,750$341.6K$350.0K0.02%+$8.4K
Centessa Pharmaceuticals PLCADS014,888+14,888$0$214.1K0.02%+$214.1K
Achilles Therapeutics PLCADS1,500,0000-1,500,000$1.71M$0—-$1.71M
Agilent Technologies, Inc.(A)75,0000-75,000$10.08M$0—-$10.08M
Allogene Therapeutics Inc1,500,0000-1,500,000$3.19M$0—-$3.19M
AstraZeneca PLCADR(AZN)475,0000-475,000$31.12M$0—-$31.12M
Bausch Health Cos Inc250,0000-250,000$2.02M$0—-$2.02M
BioMarin Pharmaceutical Inc.(BMRN)860,0000-860,000$56.53M$0—-$56.53M
Chimerix Inc1,400,0000-1,400,000$4.87M$0—-$4.87M
GSK plcADR(GSK)1,000,0000-1,000,000$33.82M$0—-$33.82M
Intellia Therapeutics, Inc.(NTLA)525,0000-525,000$6.12M$0—-$6.12M
Ionis Pharmaceuticals, Inc.(IONS)595,0000-595,000$20.80M$0—-$20.80M
Jazz Pharmaceuticals plcSHS USD(JAZZ)975,0000-975,000$120.07M$0—-$120.07M
Legend Biotech CorporationADS(LEGN)475,0000-475,000$15.46M$0—-$15.46M
Madrigal Pharmaceuticals, Inc.(MDGL)95,0000-95,000$29.31M$0—-$29.31M
Merck & Co., Inc.(MRK)800,0000-800,000$79.58M$0—-$79.58M
Monte Rosa Therapeutics, Inc.(GLUE)425,0000-425,000$2.95M$0—-$2.95M
Neurogene Inc.(NGNE)80,0000-80,000$1.83M$0—-$1.83M
Regeneron Pharmaceuticals, Inc.(REGN)20,0000-20,000$14.25M$0—-$14.25M
Roivant Sciences Ltd.SHS(ROIV)1,250,0000-1,250,000$14.79M$0—-$14.79M
SanofiADR(SNY)750,0000-750,000$36.17M$0—-$36.17M
Soleno Therapeutics Inc1,060,0000-1,060,000$47.65M$0—-$47.65M
TransMedics Group, Inc.(TMDX)50,0000-50,000$3.12M$0—-$3.12M
Verve Therapeutics Inc645,0000-645,000$3.64M$0—-$3.64M
Zai Lab LimitedADR(ZLAB)300,0000-300,000$7.86M$0—-$7.86M
Page 1 of 1
Vestal Point Capital, LP — 13F Holdings — Q1 2025 | TickerTrail